NEW YORK (GenomeWeb) – Thermo Fisher Scientific brand One Lambda said today that it has signed an exclusive licensing agreement with Transcriptome Sciences for its transplant rejection testing technology, the Molecular Microscope Diagnostic System (MMDx).

MMDx is a central diagnostic system that uses Thermo Fisher's MyGeneChip custom microarrays to measure transcript levels in biopsy samples, and then apply algorithms that compare those expression results to a set of reference biopsies for diagnosing organ transplant rejection. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.